# Physical Medicine and Rehabilitation Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Frida Kahlo (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI011-SYN-TD
- Date: 1944-09-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Marisol Ortega, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- To: Theo Lindqvist, MD, Physical Medicine and Rehabilitation
- Urgency: Routine, within two weeks

## Referral question

Chronic post-traumatic back, pelvic, and right leg pain after old spinal and pelvic fractures, spinal surgery, and childhood polio, in a 37-year-old painter on long-term opioid therapy. Please design a multimodal rehabilitation plan, review bracing and orthotics, including a shoe lift for her leg-length difference, and set function goals that can guide a slow opioid taper. **S**

## Questions for the consultant

1. What exercise and physical therapy program best fits her spine, pelvis, polio-affected leg, and ankle?
2. Would a shoe lift, ankle bracing, or a change in how she uses her back brace help?
3. Do any findings call for imaging, nerve testing, or an interventional procedure?
4. What function goals should we use to judge progress as the opioid dose is slowly reduced?

## Pertinent history

Constant low back and pelvic pain with burning in the right leg. It limits how long she can stand at the easel, and she has had to stop teaching at the art school; some students now come to her studio. She walks short distances with a cane and a limp from the shorter, weaker right leg, uses a wheelchair for longer outings, and wears a back brace on bad days. Today's right ankle radiograph shows post-traumatic osteoarthritis, with joint-space narrowing, osteophytes, and healed old fractures. Oxycodone 10 mg up to four times a day (60 MME) for about two and a half years from another prescriber; a single prescriber on the monitoring program and a urine drug test consistent with oxycodone only. She fears a sudden cut in her dose, and any taper will be slow and agreed with her. PEG 7.3; PHQ-9 8 with no thoughts of self-harm; 25-hydroxyvitamin D 18 ng/mL. Started today: duloxetine 30 mg, scheduled acetaminophen, diclofenac gel for the ankle, vitamin D, and naloxone. **S**

- Magdalena Carmen Frida Kahlo Calderón was born on July 6, 1907, in her parents' house in Coyoacán, Mexico City, now known as the Blue House, the daughter of Guillermo Kahlo and Matilde Calderón. **D**
- In 1913, at the age of six, Kahlo fell ill with polio; afterward her right leg was thinner, slightly shorter, and less developed, with the foot turned outward, and her father encouraged cycling and swimming. **D**
- A neurologist's retrospective review proposes that Kahlo also had a congenital spinal anomaly (spina bifida). **R**
- On September 17, 1925, at 18, Kahlo was riding a bus that was struck by a streetcar; a metal handrail impaled her through the hip and fractured her pelvis, and she had three fractures of the spinal column, a fractured collarbone, two rib fractures, a dislocated right shoulder, and eleven fractures of the right leg with a dislocated foot. **D**
- While immobilized for several months after the accident, Kahlo began to paint, using an easel adapted for painting in bed. **D**
- Kahlo lived with chronic pain for the rest of her life, underwent many operations, some with long convalescences and serious consequences, and used about 25 different corsets. **D**
- In 1944, because of increasingly limited mobility, Kahlo had to stop attending her classes at the La Esmeralda school of painting and sculpture, and some students continued to work with her at the Blue House. **D**
- Her pain has been interpreted retrospectively as including chronic neuropathic pain and central sensitization. **R**
- Kahlo's father, Guillermo Kahlo, had epilepsy and died in 1941; her mother, Matilde Calderón, died in 1932. **D**

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: ALT: 22 U/L; Creatinine: 0.72 mg/dL; eGFR: 110 mL/min/1.73 m²; 25-hydroxyvitamin D: 18 ng/mL (low); PEG pain and function score (0-10): 7.3; PHQ-9: 8. All results are synthetic.

BP 118/74 mmHg; pulse 82 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 50 kg; BMI 19.5 kg/m². All vital signs are synthetic.

## Current medications

- Oxycodone 10 mg oral tablet, one tablet every 6 hours as needed for pain, no more than four a day (60 MME a day) **S**
- Duloxetine 30 mg delayed-release oral capsule, one capsule daily **S**
- Acetaminophen 500 mg oral tablet, two tablets three times daily **S**
- Diclofenac sodium 1% topical gel, 2 g to the right ankle four times daily **S**
- Cholecalciferol (vitamin D3) 2,000 units oral tablet, one tablet daily **S**
- Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose; may repeat in the other nostril **S**

## Plan so far

- Nonopioid treatment first: duloxetine titrated to 60 mg daily, scheduled acetaminophen up to 3 g a day, and topical diclofenac for the ankle. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022); Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians (2017); CMID: Clinical Monitoring Intelligence Database, osteoarthritis and depression monographs (2026) **S**
- Opioid risk mitigation: review benefits and harms together, check the prescription drug monitoring program, urine drug test with consent, prescribe naloxone 4 mg nasal spray and teach a family member, and avoid benzodiazepines and other sedatives. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022) **S**
- Collaborative, gradual opioid taper of about 10% of the dose a month, paused if pain or function worsens; never stop opioids abruptly. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022) **S**
- Measure pain and function with the PEG at every visit and depressive symptoms with the PHQ-9 every two to four weeks; complete a structured safety assessment if the PHQ-9 reaches 10 or item 9 is positive. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022); CMID: Clinical Monitoring Intelligence Database, osteoarthritis and depression monographs (2026) **S**
- Check ALT periodically on regular acetaminophen, and replete vitamin D. Guideline: CMID: Clinical Monitoring Intelligence Database, osteoarthritis and depression monographs (2026) **S**
